ArticleCureus2025
A Case Report of Thrombotic Thrombocytopenic Purpura.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombotic thrombocytopenic purpura (TTP) is a rare and potentially life-threatening condition characterized by fever, microangiopathic hemolytic anemia, thrombocytopenia, renal injury, and neurologic dysfunction. Until the advancements in treatment modalities in the late 20th century, TTP had carried a very high mortality risk. Treatment based on established guidelines has drastically reduced mortality rates, making early diagnosis and therapeutic intervention critically important. This case report discusses two patients diagnosed with TTP who had varying presentations, treatment courses, and recovery. The first case involves a 19-year-old male who initially presented with symptoms of a headache with some migraine-like features, which progressed to more severe neurological deficits before the diagnosis was made. The second case describes a 61-year-old female who presented with slurred speech but was seen to have TTP, which was refractory to initial management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.